Skip to content

Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics

Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics:A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04120259
Enrollment
126
Registered
2019-10-09
Start date
2019-04-22
Completion date
2019-08-26
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

'This study aims to compare the effect of Metformin alone vs Metformin plus Apple Cider Vinegar in newly diagnosed Type 2 Diabetic Patients

Detailed description

Diabetes Mellitus is one of the oldest diseases known to men and has been treated with multiple agents,organic and with the current pharmacological advancement,with multiple synthetic drugs as well. Metformin has been considered first line for the treatment of Type 2 Diabetes, however presents itself with a side effect profile of GI distress, Vitamin B12 deficiency,to name a few. Vinegar has been used as therapeutic agent for centuries for multiple ailments including diabetes. This study aims to evaluate the combined effects of drug and natural therapy and compare it with conventional therapy.

Interventions

A biguanide drug used as a first line therapy for Diabetes MellitusType 2

DIETARY_SUPPLEMENTVinegar

A common herbal/dietary supplement used for centuries as an anti bacterial, cleaning,cooking, anti diabetic agent, to name a few uses.

Sponsors

Ziauddin University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Recently diagnosed Type 2 diabetic patients taking metformin 750 mg daily as the oral antidiabetic agent * Patients with Hemoglobin A1c in the range of 6.5 to 7.5%

Exclusion criteria

* All newly diagnosed Diabetic Patients requiring a dosage other than 750 mg per day * Patients on Insulin Therapy or any drugs for diabetes other than Metformin * Pregnant and Lactating women * Patients with food allergies to either apple or any source of vinegar * Patients unable to communicate efficiently\\mentally challenged * Type 2 Diabetic patients with any of the complications of long standing uncontrolled diabetes

Design outcomes

Primary

MeasureTime frameDescription
BMI (Anthropometric Measurement)12 weeksBody Mass Index: A measure of obesity calculated as weight in kilograms divided by height in meters square
Measurement of Hemoglobin A1c12 weeksA blood test for Glycated Hemoglobin that represents a 2-3 month glycemic control
Measurement of Fasting Blood Sugar12 weeksA blood test that involves the measurement of plasma glucose after 8 to 12 hours of fasting

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026